Back to Journals » OncoTargets and Therapy » Volume 6

Subcutaneous trastuzumab: development of a new formulation for treatment of HER2-positive early breast cancer

Total article views   HTML views PDF downloads Totals
19,479 Dovepress* 12,249+ 2,124 14,373
PubMed Central* 7,230 1,529 8,759
Totals 19,479 3,653 23,132
*Since 14 February 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
26 1 0 0 3 22

View citations on PubMed Central and Google Scholar